Clinical trial
Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis
NCT03268668 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis
- Lead sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 13, 2017
- Completion date
- January 1, 2028
- Enrollment
- 1,200 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
biological specimen banks, biomarkers, etiology, prognosis, stroke, acute